Gene Review:
Cys1 - cystin 1
Mus musculus
Synonyms:
2900006B19Rik, AV218859, Ccap, Cilia-associated protein, Cystin-1, ...
- Increased endothelin and endothelin receptor mRNA expression in polycystic kidneys of cpk mice. Nakamura, T., Ebihara, I., Fukui, M., Osada, S., Tomino, Y., Masaki, T., Goto, K., Furuichi, Y., Koide, H. J. Am. Soc. Nephrol. (1993)
- Development of autosomal recessive polycystic kidney disease in BALB/c-cpk/cpk mice. Ricker, J.L., Gattone, V.H., Calvet, J.P., Rankin, C.A. J. Am. Soc. Nephrol. (2000)
- Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules. Rankin, C.A., Suzuki, K., Itoh, Y., Ziemer, D.M., Grantham, J.J., Calvet, J.P., Nagase, H. Kidney Int. (1996)
- Structure-function relationships and site of action of apamin, a neurotoxic polypeptide of bee venom with an action on the central nervous system. Vincent, J.P., Schweitz, H., Lazdunski, M. Biochemistry (1975)
- Epidermal growth factor ameliorates autosomal recessive polycystic kidney disease in mice. Gattone, V.H., Lowden, D.A., Cowley, B.D. Dev. Biol. (1995)
- Taxol inhibits progression of congenital polycystic kidney disease. Woo, D.D., Miao, S.Y., Pelayo, J.C., Woolf, A.S. Nature (1994)
- The transcription factor hepatocyte nuclear factor-6 controls the development of pancreatic ducts in the mouse. Pierreux, C.E., Poll, A.V., Kemp, C.R., Clotman, F., Maestro, M.A., Cordi, S., Ferrer, J., Leyns, L., Rousseau, G.G., Lemaigre, F.P. Gastroenterology (2006)
- Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease. Cowley, B.D., Smardo, F.L., Grantham, J.J., Calvet, J.P. Proc. Natl. Acad. Sci. U.S.A. (1987)
- Germline and somatic loss of function of the mouse cpk gene causes biliary ductal pathology that is genetically modulated. Guay-Woodford, L.M., Green, W.J., Lindsey, J.R., Beier, D.R. Hum. Mol. Genet. (2000)
- Polycystic kidney and liver disease and corticosterone changes in the cpk mouse. Crocker, J.F., Blecher, S.R., Givner, M.L., McCarthy, S.C. Kidney Int. (1987)
- Defective epidermal growth factor gene expression in mice with polycystic kidney disease. Gattone, V.H., Andrews, G.K., Niu, F.W., Chadwick, L.J., Klein, R.M., Calvet, J.P. Dev. Biol. (1990)
- Tissue inhibitor of matrix metalloproteinase-1 suppresses apoptosis of mouse bone marrow stromal cell line MBA-1. Guo, L.J., Luo, X.H., Xie, H., Zhou, H.D., Yuan, L.Q., Wang, M., Liao, E.Y. Calcif. Tissue Int. (2006)
- Elevated proto-oncogene expression in polycystic kidneys of the C57BL/6J (cpk) mouse. Cowley, B.D., Chadwick, L.J., Grantham, J.J., Calvet, J.P. J. Am. Soc. Nephrol. (1991)
- Differential expression of Cux-1 and p21 in polycystic kidneys from Pkd1 null and cpk mice. Sharma, M., Brantley, J.G., Alcalay, N.I., Zhou, J., Heystek, E., Maser, R.L., Vanden Heuvel, G.B. Kidney Int. (2005)
- Arrested testis development in the cpk mouse may be the result of abnormal steroid metabolism. Aziz, N., Anderson, E., Lee, G.Y., Woo, D.D. Mol. Cell. Endocrinol. (2001)
- Role of the cysteine-rich domain of the t-SNARE component, SYNDET, in membrane binding and subcellular localization. Koticha, D.K., Huddleston, S.J., Witkin, J.W., Baldini, G. J. Biol. Chem. (1999)
- The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. Yoder, B.K., Hou, X., Guay-Woodford, L.M. J. Am. Soc. Nephrol. (2002)
- Enhanced stability of recombinant keratinocyte growth factor by mutagenesis. Hsu, E., Osslund, T., Nybo, R., Chen, B.L., Kenney, W.C., Morris, C.F., Arakawa, T., Narhi, L.O. Protein Eng. Des. Sel. (2006)
- Aberrant 11beta-hydroxysteroid dehydrogenase-1 activity in the cpk mouse: implications for regulation by the Ke 6 gene. Aziz, N., Brown, D., Lee, W.S., Naray-Fejes-Toth, A. Endocrinology (1996)
- Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. Gattone, V.H., Maser, R.L., Tian, C., Rosenberg, J.M., Branden, M.G. Dev. Genet. (1999)
- Coordinate regulation of 11 beta-HSD and Ke 6 genes in cpk mouse: implications for steroid metabolic defect in PKD. Aziz, N., Maxwell, M.M., Brenner, B.M. Am. J. Physiol. (1994)
- Multiorgan mRNA misexpression in murine autosomal recessive polycystic kidney disease. Gattone, V.H., Ricker, J.L., Trambaugh, C.M., Klein, R.M. Kidney Int. (2002)
- The SGP-2 gene is developmentally regulated in the mouse kidney and abnormally expressed in collecting duct cysts in polycystic kidney disease. Harding, M.A., Chadwick, L.J., Gattone, V.H., Calvet, J.P. Dev. Biol. (1991)
- Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease. Ostrom, L., Tang, M.J., Gruss, P., Dressler, G.R. Dev. Biol. (2000)
- Localization of overexpressed c-myc mRNA in polycystic kidneys of the cpk mouse. Harding, M.A., Gattone, V.H., Grantham, J.J., Calvet, J.P. Kidney Int. (1992)
- Epidermal growth factor receptor expression is abnormal in murine polycystic kidney. Orellana, S.A., Sweeney, W.E., Neff, C.D., Avner, E.D. Kidney Int. (1995)
- Abnormal tenascin expression in murine autosomal recessive polycystic kidneys. Ojeda, J.L. Nephron (1999)
- Cpk is a novel class of Drosophila PtdIns 3-kinase containing a C2 domain. Molz, L., Chen, Y.W., Hirano, M., Williams, L.T. J. Biol. Chem. (1996)